Effects of Viscous Hyaluronate–Sodium Solutions on the Nasal Absorption of Vasopressin and An Analogue
Effects of Viscous Hyaluronate–Sodium Solutions on the Nasal Absorption of Vasopressin and An Analogue
复制标题
DOI:
10.1023/a:1015894910416
复制
发表时间:
1991-04
影响因子:
3.7
通讯作者:
K. Morimoto;H. Yamaguchi;Y. Iwakura;K. Morisaka;Y. Ohashi;Y. Nakai
中科院分区:
文献类型:
--
作者:
K. Morimoto;H. Yamaguchi;Y. Iwakura;K. Morisaka;Y. Ohashi;Y. Nakai
The effects of viscous solutions of hyaluronate-sodium of various average molecular weights (MW) on the nasal absorption of vasopressin (AVP) and its analogue, l-deamino-8-D-arginine vasopressin (l-d-8-DAVP), were examined in rats. Solutions of hyaluronate with MW greater than 3 × 105daltons enhanced the nasal absorption of AVP; solutions of MW 5.5 × 104daltons were not effective. The enhancing effects on the nasal absorption of AVP and l-d-8-DAVP were dependent on the concentration in the range of 0–1.5% (w/v) hyaluronate (MW 1.4 × 106daltons). The nasal absorption of AVP was increased with this solution at lower pH. Bioavailabilities after nasal administration of AVP and l-d-8-DAVP in hyaluronate solutions (MW 1.4 × 106and 2 × 106daltons) increased more than 2- and 1.6-fold as compared to nasal administration of AVP and 1-d-8-DAVP in buffer solutions (pH 7.0), respectively. Hyaluronate solution (MW 1.4 × 106daltons) did not affect the ciliary beat frequency of rabbit nasal mucosal membranesin vitro. Therefore, hyaluronate solution may be useful as a vehicle for nasal delivery of AVP and l-d-8-DAVP.